Table 2.
Content of successive samples of YouTube videos about COVID-19 vaccination, July through December 2020.
| Content covered | July 2020 | December 2020 | |||||
|
|
Number of videos (n) | Number of views (n) | Percentage of cumulative views (%) | Number of videos (n) | Number of views (n) | Percentage of cumulative views (%) | |
| Vaccine development | 77 | 47,745,687 | 86.7 | 93 | 52,907,010 | 92.0 | |
| Fast-tracking | 57 | 31,891,480 | 57.9 | 70 | 40,140,849 | 69.8 | |
| Emergency use authorization | 3 | 593,609 | 1.1 | 22 | 10,132,084 | 17.6 | |
| Vaccine manufacturing | 31 | 17,498,885 | 31.8 | 36 | 18,817,111 | 32.7 | |
| Vaccine dissemination | 17 | 10,197,203 | 18.5 | 27 | 14,732,085 | 25.6 | |
| Vaccine eligibility | 12 | 5,410,203 | 9.8 | 25 | 9,652,883 | 16.8 | |
| Vaccine dosing |
4 | 2,217,251 | 4.0 | 26 | 9,017,039 | 15.7 | |
| Herd immunity |
5 | 2,286,901 | 4.2 | 6 | 3,173,062 | 5.5 | |
| Adverse reactions to the vaccine | 11 | 6,456,465 | 11.7 | 31 | 15,686,832 | 27.3 | |
| Fear | 6 | 1,449,915 | 2.6 | 20 | 9,553,368 | 16.6 | |
| Concerns about effectiveness | 6 | 5,966,961 | 10.8 | 25 | 12,317,526 | 21.4 | |
| Concerns about immunity duration | 5 | 2,415,092 | 4.4 | 10 | 3,953,045 | 6.9 | |